Related Experiment Video

Updated: Aug 13, 2026

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
09:34

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

Increased bone marrow angiogenesis in children with severe chronic neutropenia treated with granulocyte

Melanie Cotter1, Christian Gulmann, Michael Jeffers

  • 1Department of Hematology, Children's University Hospital, Temple Street, Dublin, Ireland. melanie.cotter@tsch.ie

Journal of Pediatric Hematology/Oncology
|July 31, 2004
PubMed

Insights

Granulocyte colony-stimulating factor (G-CSF) treatment for severe chronic neutropenia (SCN) in children increased blood vessel formation. This suggests G-CSF may enhance angiogenesis, potentially aiding in infection management for SCN patients.

Area of Science:

  • Hematology
  • Oncology
  • Vascular Biology

Background:

  • Severe chronic neutropenia (SCN) is a condition marked by low neutrophil counts and frequent infections.
  • Granulocyte colony-stimulating factor (G-CSF) is a standard treatment for SCN.
  • G-CSF has been suggested to play a role in promoting angiogenesis.

Purpose of the Study:

  • To investigate the impact of G-CSF on angiogenesis in pediatric patients with SCN.
  • To assess changes in bone marrow microvessel density during G-CSF therapy.

Main Methods:

  • Bone marrow biopsies were collected from nine children with SCN before and during G-CSF treatment.
  • Microvessel density was quantified in biopsy samples to assess angiogenesis.

Main Results:

  • All patients exhibited increased microvessel density in bone marrow biopsies after initiating G-CSF treatment.
  • This indicates enhanced angiogenesis in response to G-CSF therapy.

Conclusions:

  • G-CSF treatment appears to stimulate angiogenesis in children with SCN.
  • The observed increase in angiogenesis may be a direct effect of G-CSF on endothelial cells or an indirect consequence of elevated neutrophil counts.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate10:32

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate

Published on: May 19, 2023

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...